isoproterenol has been researched along with 293b cpd in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (90.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antzelevitch, C; Shimizu, W | 2 |
| Antzelevitch, C; Burashnikov, A | 1 |
| Camelliti, P; Cooper, PJ; Kohl, P; Lei, M | 1 |
| Ding, WG; Matsuura, H; Toyoda, F | 1 |
| Beekman, JD; Gerlach, U; Sipido, KR; Spätjens, RL; Stengl, M; van Opstal, JM; Volders, PG; Vos, MA | 1 |
| Abi-Gerges, N; Hammond, TG; Lawrence, CL; Pollard, CE; Small, BG; Valentin, JP | 1 |
| Bányász, T; Birinyi, P; Horváth, B; Magyar, J; Nánási, PP; Szentandrássy, N | 1 |
| Dong, MQ; Gao, Z; Lau, CP; Li, GR; Tseng, GN | 1 |
| Ashihara, T; Honjo, H; Inada, S; Kamiya, K; Kato, S; Kodama, I; Nakazawa, K; Okuno, Y; Opthof, T; Sakuma, I; Suzuki, T; Takanari, H; Takemoto, Y | 1 |
10 other study(ies) available for isoproterenol and 293b cpd
| Article | Year |
|---|---|
Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome.
Topics: Action Potentials; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Chromans; Cnidarian Venoms; Disease Models, Animal; Dogs; Electrocardiography; Heart Conduction System; Heart Rate; Heart Ventricles; Isoproterenol; Long QT Syndrome; Neurotoxins; Potassium Channel Blockers; Propranolol; Sotalol; Sulfonamides; Sympathetic Nervous System; Treatment Outcome | 2000 |
Block of I(Ks) does not induce early afterdepolarization activity but promotes beta-adrenergic agonist-induced delayed afterdepolarization activity.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Chromans; Delayed Rectifier Potassium Channels; Dogs; Drug Therapy, Combination; Electrophysiology; Endocardium; Heart Ventricles; Isoproterenol; Microelectrodes; Pericardium; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Purkinje Fibers; Sulfonamides; Ventricular Function | 2000 |
Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cardiotonic Agents; Chromans; Cnidarian Venoms; Dogs; Electrocardiography; Electrophysiology; Heart; Isoproterenol; Long QT Syndrome; Nicorandil; Potassium Channels; Reaction Time; Sotalol; Sulfonamides; Torsades de Pointes | 2000 |
Role of the 293b-sensitive, slowly activating delayed rectifier potassium current, i(Ks), in pacemaker activity of rabbit isolated sino-atrial node cells.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Chromans; Dose-Response Relationship, Drug; Isoproterenol; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Rabbits; Sinoatrial Node; Sulfonamides | 2002 |
Blocking action of chromanol 293B on the slow component of delayed rectifier K(+) current in guinea-pig sino-atrial node cells.
Topics: Animals; Chromans; Delayed Rectifier Potassium Channels; Dose-Response Relationship, Drug; Guinea Pigs; In Vitro Techniques; Isoproterenol; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Sinoatrial Node; Sulfonamides | 2002 |
Probing the contribution of IKs to canine ventricular repolarization: key role for beta-adrenergic receptor stimulation.
Topics: Adrenergic beta-Agonists; Anilides; Animals; Anti-Arrhythmia Agents; Cells, Cultured; Chromans; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiologic Techniques, Cardiac; Heart Ventricles; Isoproterenol; Myocytes, Cardiac; Potassium Channel Blockers; Potassium Channels; Propanolamines; Receptors, Adrenergic, beta; Sulfonamides; Ventricular Function; Wakefulness | 2003 |
Gender differences in the slow delayed (IKs) but not in inward (IK1) rectifier K+ currents of canine Purkinje fibre cardiac action potential: key roles for IKs, beta-adrenoceptor stimulation, pacing rate and gender.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Barium Compounds; Cardiac Pacing, Artificial; Chlorides; Chromans; Dogs; Electric Stimulation; Female; In Vitro Techniques; Isoproterenol; Male; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Potassium Channels, Voltage-Gated; Purkinje Fibers; Receptors, Adrenergic, beta; Sex Factors; Sulfonamides; Time Factors | 2006 |
Contribution of I Ks to ventricular repolarization in canine myocytes.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Cell Polarity; Chromans; Computer Simulation; Delayed Rectifier Potassium Channels; Dogs; Female; Heart Rate; Heart Ventricles; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocytes, Cardiac; Piperidines; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Pyridines; Sulfonamides; Sympathetic Nervous System; Ventricular Function | 2006 |
Characterization of recombinant human cardiac KCNQ1/KCNE1 channels (I (Ks)) stably expressed in HEK 293 cells.
Topics: Action Potentials; Adrenergic beta-Agonists; Barium; Cells, Cultured; Chromans; Cyclic AMP-Dependent Protein Kinases; Gene Expression Regulation; Humans; Isoproterenol; Isoquinolines; KCNQ1 Potassium Channel; Kidney; Membrane Potentials; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Protein Kinase Inhibitors; Recombinant Proteins; Sulfonamides; Transfection | 2006 |
Pharmacological blockade of IKs destabilizes spiral-wave reentry under β-adrenergic stimulation in favor of its early termination.
Topics: Action Potentials; Adrenergic Agents; Animals; Arrhythmias, Cardiac; Chromans; Heart Ventricles; Isoproterenol; Myocardium; Piperidines; Potassium Channel Blockers; Potassium Channels; Pyridines; Rabbits; Sulfonamides; Sympathetic Nervous System | 2012 |